FDA asks judge for 55 years to release data on Pfizer vaccine license decision

0
639
(AP Photo/Richard Drew, File)

By Donna Rachel Edmunds, World Israel News

The American Food and Drug Administration (FDA) has asked a judge to give the agency until 2076 to fully release the data it used when deciding to grant a license to Pfizer’s Covid vaccine. If the FDA is successful, it would mean the public having to wait a staggering 55 years to be fully informed on how the decision was made.

The request has come in response to legal action being brought by Public Health and Medical Professionals for Transparency (PHMPT), a nonprofit comprising of public health professionals, medical professionals, scientists, and journalists.

The FDA has repeatedly stated publicly that it has a “commitment to ensuring full transparency, dialogue and efficiency.”

In a statement made November last year in relation to the Moderna vaccine, a spokesman said: “The FDA understands there is tremendous public interest regarding vaccines for COVID-19. We remain committed to keeping the public informed about the evaluation of the data of a potential COVID-19 vaccine, so that once available, the public and the medical community can have trust and confidence in receiving the vaccine for our families and ourselves.”

Americans float interim Iran deal idea – Israel opposes

More recently in September of this year, in a statement referring to the use of the Pfizer-BioNTech COVID-19 Vaccine as a booster shot, the FDA again affirmed their “commitment to transparency.”

Taking them at their word, in September the PHMPT filed a freedom of information request to see the data and information submitted to the FDA by Pfizer to license its COVID-19 vaccine. That information has not been released. Consequently, the PHMPT has now filed a federal lawsuit against the FDA for access to that data.

On its website, PHMPT states that its mission is “solely to obtain and disseminate the data relied upon by the FDA to license COVID-19 vaccines.

“The organization takes no position on the data other than that it should be made publicly available to allow independent experts to conduct their own review and analyses. Any data received will be made public on this website.”

A court document filed Monday in Texas reveals that the FDA has responded by requesting that the data be released on a schedule due to the quantity of material – more than 329,000 pages. However, the FDA has requested that the schedule amount to it releasing just 500 pages a month. That would mean the full content of the files would not be made public until 2076, some 55 years from now.

Aaron Siri, managing partner of Siri & Glimstad, whose firm is handling the case on behalf of PHMPT, wrote in a Substack post:

balance of natureDonate